Gene :: Application of Genomatix in silico methods reveals novel cancer associated genes
Genomatix Software GmbH, an in silico systems biology company with headquarter in Munich, Germany, released today that researcher in Dublin, Ireland, and Boston, Mass., USA, identified novel cancer associated genes, based on strategies and products developed and promoted by Genomatix. Experimental verification by siRNA knock-down and RT-PCR confirmed the in silico results.